Siegel N, Wongsurawat N, Armbrecht H J
J Biol Chem. 1986 Dec 25;261(36):16998-7003.
Parathyroid hormone (PTH) stimulates the renal conversion of 25-OH-vitamin D3 to 1,25-(OH)2-vitamin D3 in young animals. There is evidence that PTH acts via cAMP and cAMP-dependent protein kinase, but the identity of the phosphorylated protein(s) is unknown. The present study investigates the possibility that phosphorylation modification of specific components of the renal mitochondrial, cytochrome P-450-linked 25-OH-vitamin D3-1 alpha-hydroxylase is involved in the regulation of 1,25-(OH)2-vitamin D3 production. Mitochondria were isolated from [32P]phosphate-labeled renal cortical slices which had been divided into control and agonist-treated groups. The hydroxylase protein components from the solubilized mitochondria were partially purified using p-chloroamphetamine-Sepharose affinity chromatography and polyacrylamide gel electrophoresis. Phosphorylation was observed only in a protein with an Mr = 12,000 and a pI of 4.2 by autoradiography of the gels. This radiolabeled protein was immunoprecipitated with adrenodoxin antibody. Additionally, the protein in the same Mr region of the polyacrylamide gel reacted with adrenodoxin antibody and co-migrated with bovine adrenodoxin. PTH and forskolin treatment resulted in decreased phosphate incorporation into the protein, whereas A23187 treatment increased the phosphorylation. In parallel experiments, affinity-isolated hydroxylase from control and PTH-treated slices was used to assess in vitro hydroxylase activity using [3H]25-hydroxyvitamin D3 as substrate. The hydroxylase activity derived from PTH-treated tissue was significantly higher than that of control. From these data, it is proposed that renal response to PTH in terms of 25-hydroxyvitamin D3 hydroxylase stimulation involves dephosphorylation of renoredoxin, the ferrodoxin component of this hydroxylase complex.
甲状旁腺激素(PTH)可刺激幼龄动物肾脏将25-羟基维生素D3转化为1,25-二羟基维生素D3。有证据表明,PTH通过环磷酸腺苷(cAMP)和cAMP依赖性蛋白激酶发挥作用,但被磷酸化的蛋白的具体身份尚不清楚。本研究探讨了肾脏线粒体中与细胞色素P-450相关的25-羟基维生素D3-1α-羟化酶的特定成分的磷酸化修饰是否参与1,25-二羟基维生素D3生成调控的可能性。线粒体从[32P]磷酸盐标记的肾皮质切片中分离出来,这些切片被分为对照组和激动剂处理组。用对氯苯丙胺-琼脂糖亲和层析和聚丙烯酰胺凝胶电泳对溶解的线粒体中的羟化酶蛋白成分进行部分纯化。通过凝胶放射自显影观察到,仅在一种分子量为12,000、等电点为4.2的蛋白中出现了磷酸化。这种放射性标记的蛋白用肾上腺铁氧还蛋白抗体进行免疫沉淀。此外,聚丙烯酰胺凝胶中相同分子量区域的蛋白与肾上腺铁氧还蛋白抗体发生反应,并与牛肾上腺铁氧还蛋白共迁移。PTH和福斯可林处理导致该蛋白的磷酸盐掺入减少,而A23187处理则增加了磷酸化。在平行实验中,使用来自对照组和PTH处理组切片的亲和分离的羟化酶,以[3H]25-羟基维生素D3为底物评估体外羟化酶活性。来自PTH处理组织的羟化酶活性显著高于对照组。根据这些数据,提出肾脏对PTH刺激25-羟基维生素D3羟化酶的反应涉及该羟化酶复合物的铁氧还蛋白成分——肾铁氧还蛋白的去磷酸化。